Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC‐induced cholestatic injury by promoting a pro‐restorative inflammatory response-Reference-Cited by-同舟云学术

Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC‐induced cholestatic injury by promoting a pro‐restorative inflammatory response

Published:2022-09-23 Issue:3 Volume:258 Page:312-324
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:The Journal of Pathology

Author:

Lazcanoiturburu Nerea¹^ORCID,García‐Sáez Juan¹^ORCID,González‐Corralejo Carlos¹^ORCID,Roncero Cesáreo¹^ORCID,Sanz Julián²³^ORCID,Martín‐Rodríguez Carlos¹^ORCID,Valdecantos M Pilar⁴⁵^ORCID,Martínez‐Palacián Adoración¹,Almalé Laura¹^ORCID,Bragado Paloma¹^ORCID,Calero‐Pérez Silvia⁴⁵^ORCID,Fernández Almudena⁶^ORCID,García‐Bravo María⁷⁸^ORCID,Guerra Carmen⁹^ORCID,Montoliu Lluis⁶^ORCID,Segovia José Carlos⁷⁸^ORCID,Valverde Ángela M⁴⁵^ORCID,Fabregat Isabel¹⁰¹¹¹²^ORCID,Herrera Blanca¹^ORCID,Sánchez Aránzazu¹^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, Faculty of Pharmacy Complutense University of Madrid (UCM), Health Research Institute of the ‘Hospital Clínico San Carlos’ (IdISSC) Madrid Spain

2. Anatomical Pathology Service of the ‘Clínica Universidad de Navarra’ Madrid Spain

3. Department of Psychiatry, Legal Medicine and Anatomical Pathology, Faculty of Medicine UCM Madrid Spain

4. ‘Alberto Sols’ Biomedical Research Institute, Spanish National Research Council and Autonomous University of Madrid (IIBM, CSIC‐UAM) Madrid Spain

5. Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders of the Carlos III Health Institute (CIBERDEM‐ISCIII) Madrid Spain

6. National Center for Biotechnology (CNB‐CSIC), Biomedical Research Networking Center on Rare Diseases (CIBERER‐ISCIII) Madrid Spain

7. Cell Technology Division, Research Center for Energy, Environment and Technology (CIEMAT) Biomedical Research Networking Center on Rare Diseases (CIBERER‐ISCIII) Madrid Spain

8. Advanced Therapies Mixed Unit ‘Fundación Jiménez Díaz’ University Hospital Health Research Institute (CIEMAT/IIS‐FJD) Madrid Spain

9. Molecular Oncology Programme Spanish National Cancer Research Center (CNIO) Madrid Spain

10. TGF‐β and Cancer Group, Oncobell Program Bellvitge Biomedical Research Institute (IDIBELL) Barcelona Spain

11. Oncology Program, Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBEREHD‐ISCIII) Madrid Spain

12. Department of Physiological Sciences, Faculty of Medicine and Health Sciences University of Barcelona (UB) Barcelona Spain

Funder

Ministry of Science, Innovation and Universities

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.6002

Reference59 articles.

1. EGFR Signaling in Liver Diseases

2. Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis

3. The EGF receptor is required for efficient liver regeneration

4. RNA Interference Against Hepatic Epidermal Growth Factor Receptor Has Suppressive Effects on Liver Regeneration in Rats

5. The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astragalin protects against lipopolysaccharide-triggered acute liver injury through suppression of necroptosis and inflammation and improvement of energy metabolism;Journal of Functional Foods;2024-07

2. The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche;The Journal of Pathology;2024-06-14

3. Network toxicology and molecular docking for the toxicity analysis of food contaminants: A case of Aflatoxin B1;Food and Chemical Toxicology;2024-06

4. Molecular Insights of Cholestasis in MDR2 Knockout Murine Liver Organoids;Journal of Proteome Research;2024-03-15

5. NLRP3 deficiency protects against acetaminophen‑induced liver injury by inhibiting hepatocyte pyroptosis;Molecular Medicine Reports;2024-02-20